Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.

Prochnow H, Rox K, Birudukota NVS, Weichert L, Hotop SK, Klahn P, Mohr K, Franz S, Banda DH, Blockus S, Schreiber J, Haid S, Oeyen M, Martinez JP, Süssmuth RD, Wink J, Meyerhans A, Goffinet C, Messerle M, Schulz TF, Kröger A, Schols D, Pietschmann T, Brönstrup M.

J Virol. 2020 Jan 6;94(2). pii: e01471-19. doi: 10.1128/JVI.01471-19. Print 2020 Jan 6.

PMID:
31666384
2.

Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor.

Passos V, Zillinger T, Casartelli N, Wachs AS, Xu S, Malassa A, Steppich K, Schilling H, Franz S, Todt D, Steinmann E, Sutter K, Dittmer U, Bohne J, Schwartz O, Barchet W, Goffinet C.

J Virol. 2019 Nov 26;93(24). pii: e01221-19. doi: 10.1128/JVI.01221-19. Print 2019 Dec 15.

3.

Quantitative Proteomics of Uukuniemi Virus-host Cell Interactions Reveals GBF1 as Proviral Host Factor for Phleboviruses.

Uckeley ZM, Moeller R, Kühn LI, Nilsson E, Robens C, Lasswitz L, Lindqvist R, Lenman A, Passos V, Voss Y, Sommerauer C, Kampmann M, Goffinet C, Meissner F, Överby AK, Lozach PY, Gerold G.

Mol Cell Proteomics. 2019 Dec;18(12):2401-2417. doi: 10.1074/mcp.RA119.001631. Epub 2019 Sep 30.

PMID:
31570497
4.

SIVcol Nef counteracts SERINC5 by promoting its proteasomal degradation but does not efficiently enhance HIV-1 replication in human CD4+ T cells and lymphoid tissue.

Kmiec D, Akbil B, Ananth S, Hotter D, Sparrer KMJ, Stürzel CM, Trautz B, Ayouba A, Peeters M, Yao Z, Stagljar I, Passos V, Zillinger T, Goffinet C, Sauter D, Fackler OT, Kirchhoff F.

PLoS Pathog. 2018 Aug 20;14(8):e1007269. doi: 10.1371/journal.ppat.1007269. eCollection 2018 Aug.

5.

Susceptibility of Chikungunya Virus to Inactivation by Heat and Commercially and World Health Organization-Recommended Biocides.

Franz S, Friesland M, Passos V, Todt D, Simmons G, Goffinet C, Steinmann E.

J Infect Dis. 2018 Sep 22;218(9):1507-1510. doi: 10.1093/infdis/jiy359.

6.

The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.

Lodermeyer V, Ssebyatika G, Passos V, Ponnurangam A, Malassa A, Ewald E, Stürzel CM, Kirchhoff F, Rotger M, Falk CS, Telenti A, Krey T, Goffinet C.

J Virol. 2018 Jun 29;92(14). pii: e00226-18. doi: 10.1128/JVI.00226-18. Print 2018 Jul 15.

7.

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A.

Retrovirology. 2017 Oct 18;14(1):48. doi: 10.1186/s12977-017-0372-3.

8.

[cGAS, an antiviral weapon: role in the recognition of HIV-1 transmitted from cell to cell].

Ducroux A, Goffinet C.

Med Sci (Paris). 2017 Aug-Sep;33(8-9):732-734. doi: 10.1051/medsci/20173308015. Epub 2017 Sep 18. French. No abstract available.

9.

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells.

Geis FK, Galla M, Hoffmann D, Kuehle J, Zychlinski D, Maetzig T, Schott JW, Schwarzer A, Goffinet C, Goff SP, Schambach A.

Retrovirology. 2017 May 31;14(1):34. doi: 10.1186/s12977-017-0358-1. Erratum in: Retrovirology. 2017 Oct 18;14(1):48.

10.

Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs.

Siddharta A, Pfaender S, Malassa A, Doerrbecker J, Anggakusuma, Engelmann M, Nugraha B, Steinmann J, Todt D, Vondran FW, Mateu-Gelabert P, Goffinet C, Steinmann E.

Sci Rep. 2016 Nov 18;6:36619. doi: 10.1038/srep36619.

11.

cGAS-Mediated Innate Immunity Spreads Intercellularly through HIV-1 Env-Induced Membrane Fusion Sites.

Xu S, Ducroux A, Ponnurangam A, Vieyres G, Franz S, Müsken M, Zillinger T, Malassa A, Ewald E, Hornung V, Barchet W, Häussler S, Pietschmann T, Goffinet C.

Cell Host Microbe. 2016 Oct 12;20(4):443-457. doi: 10.1016/j.chom.2016.09.003.

12.
13.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28.

PMID:
25999047
14.

90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.

Lodermeyer V, Suhr K, Schrott N, Kolbe C, Stürzel CM, Krnavek D, Münch J, Dietz C, Waldmann T, Kirchhoff F, Goffinet C.

Retrovirology. 2013 Oct 24;10:111. doi: 10.1186/1742-4690-10-111.

15.

Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses.

Yolamanova M, Meier C, Shaytan AK, Vas V, Bertoncini CW, Arnold F, Zirafi O, Usmani SM, Müller JA, Sauter D, Goffinet C, Palesch D, Walther P, Roan NR, Geiger H, Lunov O, Simmet T, Bohne J, Schrezenmeier H, Schwarz K, Ständker L, Forssmann WG, Salvatella X, Khalatur PG, Khokhlov AR, Knowles TP, Weil T, Kirchhoff F, Münch J.

Nat Nanotechnol. 2013 Feb;8(2):130-6. doi: 10.1038/nnano.2012.248. Epub 2013 Jan 20.

PMID:
23334171
16.

Reacquisition of Nef-mediated tetherin antagonism in a single in vivo passage of HIV-1 through its original chimpanzee host.

Götz N, Sauter D, Usmani SM, Fritz JV, Goffinet C, Heigele A, Geyer M, Bibollet-Ruche F, Learn GH, Fackler OT, Hahn BH, Kirchhoff F.

Cell Host Microbe. 2012 Sep 13;12(3):373-80. doi: 10.1016/j.chom.2012.07.008.

17.

The cellular antiviral restriction factor tetherin does not inhibit poxviral replication.

Sliva K, Resch T, Kraus B, Goffinet C, Keppler OT, Schnierle BS.

J Virol. 2012 Feb;86(3):1893-6. doi: 10.1128/JVI.05198-11. Epub 2011 Nov 16.

18.

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans.

Erikson E, Adam T, Schmidt S, Lehmann-Koch J, Over B, Goffinet C, Harter C, Bekeredjian-Ding I, Sertel S, Lasitschka F, Keppler OT.

Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13688-93. doi: 10.1073/pnas.1101684108. Epub 2011 Aug 1.

19.

Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Goffinet C, Schmidt S, Kern C, Oberbremer L, Keppler OT.

J Virol. 2010 Nov;84(21):11374-84. doi: 10.1128/JVI.01067-10. Epub 2010 Aug 11.

20.

Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.

Goffinet C, Homann S, Ambiel I, Tibroni N, Rupp D, Keppler OT, Fackler OT.

J Virol. 2010 Apr;84(8):4089-94. doi: 10.1128/JVI.01549-09. Epub 2010 Feb 10.

Supplemental Content

Loading ...
Support Center